Guo Rui Yinuo received an “Excellent” rating in the 2024 Toxicological Pathomorphology Proficiency Testing Program.
Release time:
2024-12-03 19:11
Keywords:
Tumor,Lesion
Toxicopathological examination is an important component of preclinical toxicology evaluation for drugs. To continuously maintain excellence in the field of toxicopathological diagnosis, Relatively High level, Xixian New Area Guorui Yinuo Drug Safety Evaluation Research Limited Liability Company (hereinafter referred to as Guo Rui’s Promise ) participated in the event organized by the China National Institute for Food and Drug Control. 2024 Annual Proficiency Testing Program for Toxicological Pathomorphology NIFDC-PT-478 ), the final result Evaluation For “ Excellent ”。
A total of [number] samples were prepared for this proficiency testing program. A 、 B 、 C Three sets of cases, each set containing 10 Each case involves a neoplastic lesion. 4 Examples and Non-Tumorous Lesions 6 For example, Guorui Yinuo was assigned to this proficiency testing project. B Case series. After receiving the whole-slide images of the cases, pathologists from Guorui Yinuo Clinical Pathology Department quickly made diagnoses and completed the process within a short period of time. 10 The pathological morphological examination of the case has been completed and the results submitted; ultimately... 4 One neoplastic case and 6 The pathological diagnosis results for the non-tumor case were completed with outstanding performance, scoring above the average, and achieved a total score of... 82.5 The score is distributed across all. 92 Among the participating institutions, it ranks in the first tier (satisfactory). - Excellent.
The results of this proficiency testing program demonstrate that Guorui Yinuo is capable of accurately using pathology-specific terminology to perform toxicological morphological examinations in four key areas: histopathological diagnosis, description of diagnostic highlights, elucidation of relevant pathological mechanisms, and characterization of other lesions. Moreover, Guorui Yinuo can provide comprehensive interpretations of lesions and conduct thorough analyses of their pathogenic mechanisms. Participation in this proficiency testing program not only underscores the strong capabilities of Guorui Yinuo’s pathology diagnosticians in toxicological diagnosis and lesion analysis but also lays a solid foundation for Guorui Yinuo to further enhance its preclinical safety evaluation toxicology research and elevate its level of toxicological pathology diagnosis in the future.
Guo Rui Yinuo not only established compliance with GLP We have a standardized workflow for toxicological pathology examinations and a team of highly qualified pathologists. Our capabilities and quality in animal necropsy, tissue processing, and pathological slide preparation all meet the highest domestic and international standards, enabling us to conduct studies that comply with Chinese regulations. NMPA Standardized pathological specimen preparation and diagnostic analysis studies.
Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. was established 2018 Year 11 Yue is an independent, third-party drug safety evaluation research institution located in the Free Trade Pilot Zone of Konggang New City. Guorui Yinuo... 2021 Year 07 The drug has been approved by the National Medical Products Administration. GLP (Certification under the Good Laboratory Practice for Non-Clinical Drug Studies), becoming the first in the province to pass the national drug certification. GLP A certified non-clinical safety research institution has filled a gap in our province. GLP The laboratory’s capabilities will establish a convenient, efficient, and reliable technical platform for new drug research and preclinical safety evaluation in Shaanxi Province’s pharmaceutical industry, playing a crucial role in further enhancing Shaanxi Province’s drug R&D level, its independent innovation capacity in the pharmaceutical sector, and the quality of drug research. As an important intermediate link in the transformation of innovative drugs from the innovation chain to the industrial chain, drug safety evaluation research serves as the bridge that connects these two stages. “ Qin Chuangyuan ” The interactive integration of the innovation chain and the industrial chain in the life sciences sector holds significant value for the development of the province’s life science industry. Currently, Guorui Yinuo has obtained approval from the Ministry of Agriculture and Rural Affairs of China for veterinary drugs. GLP 、 GCP Inspection passed by the China National Accreditation Service for Conformity Assessment. CNAS GLP Certification.
Guo Rui Yinuo has been recognized by the Xi'an Municipal Bureau of Industry and Information Technology as... 2022 The innovative small and medium-sized enterprises in Shaanxi Province have been recognized by the Xi'an Science and Technology Bureau. 2022 Xi'an City of the Year “ Drug Non-Clinical Safety Evaluation Research Platform ” The Engineering and Technology Research Center has been recognized by the Xi'an Science and Technology Bureau as... 2023 Year “ Xi'an's New R&D Institutions ” , recognized by the Shaanxi Provincial Department of Science and Technology as 2024 Year “ Shaanxi Province’s New R&D Institutions ” Guo Rui Yino currently has high-level talents (local-level leading talents) from Xi'an City. 2 Name: Xixian New Area Qin Chuangyuan Innovation Talent Program - High-end innovation team 1 Zhī, Shaanxi Provincial Department of Science and Technology, Qin Chuang Yuan “ scientist + Engineer ” Team 1 Support.
Guorei Yinuo integrates drug toxicology, pathology, pharmacology, analytical testing, cosmetics, and generic drug consistency evaluation services into a single platform, possessing tremendous growth potential. The company’s building area reaches... 6400 Square meters, Phase I investment 3000 Over 100,000 yuan—currently equipped with a liquid chromatography-mass spectrometry system, high-performance liquid chromatograph, fully automatic chemiluminescence analyzer, animal blood analyzer, automated tissue dehydrator, millionth-of-a-gram balance, animal oral and nasal inhalation exposure system, UV-visible spectrophotometer, and fluorescence microscope, among others. 300 We have a comprehensive suite of instruments and equipment, and have established experimental platforms covering genetic toxicology, analytical testing, reproductive toxicology, and clinical pathology. Our company is dedicated to non-clinical safety evaluation of drugs, offering clients a one-stop service that includes personalized protocol design, drug screening, pharmacodynamic studies, pharmacokinetic studies, safety assessments, and clinical trial sample analysis. We also provide services for safety evaluations of foods, health supplements, chemicals, and cosmetics. In addition, our company has established capabilities in the development of disease-model animals and the breeding of laboratory animals. nurture and other platforms. Our company has assembled a stable, experienced, and professional team and has established systems that simultaneously comply with U.S. regulations. FDA 、 OECD And China NMPA Regulatory requirements GLP System.
In the future, Guorui Yinuo will continue to strengthen institutional development and management, strictly adhering to... GLP We are committed to conducting non-clinical safety evaluations of pharmaceuticals, effectively helping companies shorten the new drug development cycle and bringing drugs to market faster and more safely! Guo Rui Yinuo will always uphold the philosophy of “human health and environmental safety,” providing high-quality services to customers worldwide.
Related News
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681